GLAXO ZOFRAN U.S. SALES REACH $250 MIL. IN FY 1992: ANTI- EMETIC GROWING FAST, WITH POST-OP INDICATION PENDING; GLAXO MEDICAID REBATES REACH $130 MIL.

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".